ABSTRACT
A crucial step in preoperative planning for a revision total hip replacement (THR) surgery is accurate identification of failed implant design, especially if one or more well-fixed/functioning components are to be retained. Manual identification of the implant design from preoperative radiographic images can be time-consuming and inaccurate, which can ultimately lead to increased operating room time, more complex surgery, and increased healthcare costs. No automated system has been developed to accurately and efficiently identify THR implant designs. In this study, we present a novel, fully automatic and interpretable approach to identify the design of nine different THR femoral implants from plain radiographs using deep convolutional neural network (CNN). We also compared the CNN’s performance with three board-certified and fellowship trained orthopaedic surgeons. The CNN achieved on-par accuracy with the orthopaedic surgeons while being significantly faster. The need for additional training data for less distinct designs was also highlighted. Such CNN can be used to automatically identify the design of a failed THR femoral implant preoperatively in just a fraction of a second, saving time and improving identification accuracy.
Competing Interest Statement
Alireza Borjali (None), Antonia Chen (3b: Stryker, bOne, Haylard, Signature, 3M, Convatec, DePuy, Heraeus, 4: Graftworx, Joint Purification System, Sonoran, Hyalex, Irrimax, bOne 8: Journal of arthroplasty, KSSTA, BJJ 360, CORR, Arthroplasty Today, JBJS, 9: AAHKS, AAOS, MSIS), Hany S. Bedair (1: Smith & Nephew, Exactech, 3B: Smith & Nephew, Exactech, 4: Exactech, 5: Zimmer Biomet, 7: Wolters-Klover), Christopher M. Melnic (None), Orhun K. Muratoglu (1: Zimmer Biomet, Stryker Corp., Corin Group, Kyocera Inc., ConforMIS Inc., 3B-Zimmer Biomet Inc., 4: Orthopaedic Technology Group, 5: Zimmer Biomet Inc., Stryker Corp., DePuy), Mohammad A. Morid (None), Kartik M. Varadarajan (1: Stryker Corp, 4: Orthop Tech Group, 5: Medtronic, Evonik, 9: ORS)
Funding Statement
This study was supported by laboratory sundry funds, and no external funding was received. The authors have no financial disclosures relevant to this study.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The IRB protocol does not allow for publicly sharing the data. Specific requests could be directed to the corresponding author.
